Literature DB >> 21241451

E47 retroviral rescue of intrinsic B-cell defects in senescent mice.

Ana M Landin1, Daniela Frasca, Patrick Harrison, Martina Scallan, Richard L Riley, Bonnie B Blomberg.   

Abstract

In aging, immune responses are dramatically impaired, specifically the ability to produce protective antibodies. We previously showed that with age there is a B-cell intrinsic decrease in class switch recombination (CSR) because of a decrease in activation-induced cytidine deaminase (AID). One mechanism we have demonstrated for decreased AID includes increased mRNA degradation of the transcription factor E47, critical for AID transcription. Here, we show by means of a retroviral construct containing the DsRED reporter and the 3'UTR of E47 that the 3'UTR lowers mRNA expression, and particularly in B cells from old mice. This is the first demonstration that the E47 3'UTR directly regulates its degradation. The AID mRNA was not differentially regulated by degradation in aging. Therefore, we have here further established critical components for decreased AID with age. The major aim of this study was to establish conditions for the rescue of the intrinsic defect of aged B cells with retroviral addition of the coding region of E47 in splenic B cells to restore their ability to produce optimal AID and class switch to IgG. In this study, we show that young and old primary B cells overexpressing a stable E47 mRNA up-regulate E47, AID, and CSR and improve B-cell immune responses in senescent murine B cells. Our results provide a proof of principle for the rescue of intrinsic B-cell defects and the humoral immune response in senescence.
© 2011 The Authors. Aging Cell © 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21241451      PMCID: PMC4710514          DOI: 10.1111/j.1474-9726.2011.00673.x

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


  37 in total

1.  Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine.

Authors:  H Asanuma; K Hirokawa; M Uchiyama; Y Suzuki; C Aizawa; T Kurata; T Sata; S Tamura
Journal:  Vaccine       Date:  2001-07-16       Impact factor: 3.641

2.  Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Ana Marie Landin; Mitch Phillips; Suzanne C Lechner; John G Ryan; Bonnie B Blomberg
Journal:  Vaccine       Date:  2010-10-23       Impact factor: 3.641

3.  Enhanced differentiation of splenic plasma cells but diminished long-lived high-affinity bone marrow plasma cells in aged mice.

Authors:  Shuhua Han; Kaiyong Yang; Zeynep Ozen; Weiyi Peng; Ekaterina Marinova; Garnett Kelsoe; Biao Zheng
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

Review 4.  Immunosenescence and vaccine failure in the elderly.

Authors:  Beatrix Grubeck-Loebenstein; Silvia Della Bella; Anna Maria Iorio; Jean-Pierre Michel; Graham Pawelec; Rafael Solana
Journal:  Aging Clin Exp Res       Date:  2009-06       Impact factor: 3.636

5.  Protein phosphatase 2A (PP2A) is increased in old murine B cells and mediates p38 MAPK/tristetraprolin dephosphorylation and E47 mRNA instability.

Authors:  Daniela Frasca; Maria Romero; Ana Marie Landin; Alain Diaz; Richard L Riley; Bonnie B Blomberg
Journal:  Mech Ageing Dev       Date:  2010-02-26       Impact factor: 5.432

Review 6.  Effects of aging on B cell function.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Curr Opin Immunol       Date:  2009-07-14       Impact factor: 7.486

7.  Decreased E47 in senescent B cell precursors is stage specific and regulated posttranslationally by protein turnover.

Authors:  Elaine Van der Put; Daniela Frasca; Anne M King; Bonnie B Blomberg; Richard L Riley
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

8.  Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae.

Authors:  C Nicoletti; X Yang; J Cerny
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

9.  Repertoire diversity of antibody response to bacterial antigens in aged mice. II. Phosphorylcholine-antibody in young and aged mice differ in both VH/VL gene repertoire and in specificity.

Authors:  C Nicoletti; C Borghesi-Nicoletti; X H Yang; D H Schulze; J Cerny
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

10.  HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation.

Authors:  Seok-Rae Park; Hong Zan; Zsuzsanna Pal; Jinsong Zhang; Ahmed Al-Qahtani; Egest J Pone; Zhenming Xu; Thach Mai; Paolo Casali
Journal:  Nat Immunol       Date:  2009-04-12       Impact factor: 25.606

View more
  5 in total

Review 1.  Age effects on mouse and human B cells.

Authors:  Bonnie B Blomberg; Daniela Frasca
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 2.  Aging and neoteny in the B lineage.

Authors:  Doron Melamed; David W Scott
Journal:  Blood       Date:  2012-08-30       Impact factor: 22.113

3.  Aging impairs murine B cell differentiation and function in primary and secondary lymphoid tissues.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Aging Dis       Date:  2011-10-28       Impact factor: 6.745

4.  MicroRNAs miR-155 and miR-16 Decrease AID and E47 in B Cells from Elderly Individuals.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Franco Ferracci; Bonnie B Blomberg
Journal:  J Immunol       Date:  2015-07-29       Impact factor: 5.422

5.  Myc-Interacting Zinc Finger Protein 1 (Miz-1) Is Essential to Maintain Homeostasis and Immunocompetence of the B Cell Lineage.

Authors:  Eva-Maria Piskor; Julie Ross; Tarik Möröy; Christian Kosan
Journal:  Biology (Basel)       Date:  2022-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.